Thomas Luzier, MD
Allergy & Immunology · Aberdeen, SDNPI 1578595096
Payments from drug & device makers
Across 683 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Mylan Specialty L.p.$1K
- Sanofi$1K
- CSL Behring$753
- plus $4K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 101 | $1,946 |
| GSK | 121 | $1,586 |
| Takeda Pharmaceuticals U.S.A., Inc. | 79 | $1,345 |
| Mylan Specialty L.p. | 82 | $1,230 |
| Sanofi | 54 | $1,032 |
| CSL Behring | 46 | $753 |
| Grifols USA, LLC | 35 | $605 |
| Regeneron Healthcare Solutions, Inc. | 19 | $402 |
| Phathom Pharmaceuticals, Inc. | 15 | $401 |
| Boehringer Ingelheim | 22 | $325 |
| Pfizer | 16 | $273 |
| Genentech USA, Inc. | 15 | $257 |
| Sanofi-aventis U.S. LLC | 3 | $209 |
| Biocryst US Sales Co., LLC | 10 | $183 |
| Octapharma USA, Inc. | 5 | $179 |
| Viatris Specialty LLC | 13 | $173 |
| Verona Pharma, Inc. | 7 | $154 |
| Hospira, Inc. | 6 | $120 |
| Insmed, Inc. | 5 | $100 |
| Novartis | 5 | $98 |
| Shire North American Group Inc | 6 | $94 |
| Lilly USA, LLC | 3 | $80 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $56 |
| Pharming Healthcare, Inc. | 3 | $51 |
| Amgen | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Alk-abello, Inc | 1 | $22 |
| AbbVie | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| LEO Pharma Inc. | 1 | $18 |
| Merck | 1 | $16 |
How this compares
Too few allergy & immunology providers in South Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Aberdeen
- Jason SchendSioux Falls$13K
- Farah KhanRapid City$7K
- Justin HsuehSioux Falls$4K
- Abigail FinleyRapid City$3K
- Rebecca DuronSioux Falls$3K
- Keerthi BansalSioux Falls$2K
- Mark BubakSioux Falls$357
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.